GOLM1 and hepatocellular carcinoma: For HCC cases specifically, levels of GP73 were found to be significantly elevated compared to healthy individuals or those with non-malignant liver conditions, suggesting it can serve as a non-invasive biomarker for detection and monitoring of HCC, potentially aiding in early diagnosis and prognosis evaluation [45].